Website Banner Farcast Bio.png

FAST TRACK

DRUG DISCOVERY

Accelerate immuno-oncology discovery and development with our research backed histoculture platform

 

REVOLUTIONARY HUMAN TUMOR HISTOCULTURE PLATFORM

Farcast Biosciences's unique and proprietary technology uses fresh human tumor samples cultured in a proven system that recreates TiME (Tumor immune MicroEnvironment) ex vivo

The culture system maintains morphology and viability while retaining native tumor architecture and immune components to enable evaluation of tumor response to drug treatment

TiME: Tumor immune MicroEnvironment

Recreating native human TiME ex vivo

Representing tumor heterogeneity

Preserving immune compartment

Retaining ECM and stromal component

CD8

Epcam

Farcast proprietary image 

THE FARCAST ADVANTAGE

Extensive Hospital Network

Our networks include IRB approved cancer centers that provide fresh tumor samples from informed and consented patients to enable effective study of inter-patient heterogeneity

Wide Therapeutic Coverage

Our platform can evaluate therapeutic response across many drug categories including bi-specific antibodies, monoclonal antibodies, small molecules and oncolytic viruses in a short period of time

Comprehensive Assays

We offer a wide array of kinetic, and end-point assays for multi-dimensional analysis of mechanistic action and impact of therapeutic agents on tumor micro-environment in a cost effective manner

IN-VIVO MEETS EX-VIVO IN A REVOLUTIONARY PLATFORM

  • LinkedIn

Farcast Biosciences

 

Salarpuria Symphony

Commercial Building Electronic City

Bengaluru.Karnataka 560100, India

 

40 Palafox Place, Suite 300

Pensacola,

FL 32502, USA

biopharma@farcastbio.com

© 2020 by Farcast. Created with Wix.com